Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta‐analysis update

OBJECTIVE: To evaluate the diagnostic performance of short state homeobox 2 (SHOX2) promoter methylation as biomarker for lung cancer identification through aggregating the open published data. METHODS: We did an electronic search in Pubmed, EMBASE, Ovid, Web of Science, Google Scholar, and the Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaoxi, Lu, Xiaoling, Wu, Haiyan, Liu, Juan, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671898/
https://www.ncbi.nlm.nih.gov/pubmed/34741433
http://dx.doi.org/10.1111/1759-7714.14206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671898/
https://www.ncbi.nlm.nih.gov/pubmed/34741433
http://dx.doi.org/10.1111/1759-7714.14206

Ejemplares similares